FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Curcumin spice linked to slowing of lung lining cancer Sep 22, 5:25 pm
Washington, Sept 22 (ANI): A new study has revealed that Asian spice Curcumin show promise in slowing the progression of mesothelioma, a cancer of the lung's lining often linked to asbestos.
Full Story
New 'evolved' protein therapy to stop cancer growth Sep 22, 3:34 pm
Washington, Sept 22 (ANI): Researchers from Stanford has created an "evolved" protein therapy that might stop cancer from spreading in body.
Full Story
Nearly 50 pc of cancers get diagnosed late: Study Sep 22, 1:06 pm
London, Sept 22 (ANI): A new study has found that nearly half of cancers are diagnosed only when the disease is at an advanced stage, meaning treatment is both more expensive and less likely to succeed.
Full Story
Dry-roasted peanuts likelier to trigger 'allergic reactions' than raw counterparts Sep 22, 12:06 pm
London, Sep 22 (ANI): A new study has revealed that dry-roasted peanuts may pose bigger allergy threats as compared to raw peanuts.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY